Huperzine A Controlled-Release Tablets: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 2 1 Phase 3 1

Conditions being studied

Condition	Trials
Alzheimer Dementia	1
Alzheimer's disease	1

Recruiting trials involving Huperzine A Controlled-Release Tablets

Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
NCT07066826 · Phase: Phase 2, Phase 3 · Ages: 50 Years to 85 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Huperzine A Controlled-Release Tablets?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.